Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 3, 2008, Pages 392-396

  Albalushi, Talal ^a   Horiuchi, Yasue ^a,b   Ishiguro, Hiroki ^a,b   Koga, Minori ^a,b   Inada, Toshiya ^c   Iwata, Nakao ^d   Ozaki, Norio ^e   Ujike, Hiroshi ^f   Watanabe, Yuichiro ^g   Someya, Toshiyuki ^g   Arinami, Tadao ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Glutamate receptor; Haplotype; Single nucleotide polymorphism

Indexed keywords

METABOTROPIC RECEPTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENOTYPE; GRM3 GENE; HAPLOTYPE; HUMAN; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 42149189451     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30610     Document Type: Article

References (14)

1. Bishop JR, Ellingrod VL, Moline J, Miller D. 2005. Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr Res 77:253-260.
2. Chen Q, He G, Chen Q, Wu S, Xu Y, Feng G, Li Y, Wang L, He L. 2005. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res 73:21-26.
3. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR. 2004. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 101:12604-12609.
4. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77:918-936.
5. Fujii Y, Shibata H, Kikuta R, Makino C, Tani A, Hirata N, Shibata A, Ninomiya H, Tashiro N, Fukumaki Y. 2003. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 13:71-76.
6. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68.
7. Holden C. 2001. Drug addiction. Zapping memory center triggers drug craving. Science 292:1039.
8. Marti SB, Cichon S, Propping P, Nothen M. 2002. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. Am J Med Genet 114:46-4650.
9. Moghaddam B, Adams BW. 1998. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352.
10. Nakanishi S. 1992. Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603.
11. Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR. 2007. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DIS C1: Influence on risk of schizophrenia. Hum Genet 120:889-906.
12. Norton N, Williams HJ, Dwyer S, Ivanov D, Preece AC, Gerrish A, Williams NM, Yerassimou P, Zammit S, O'Donovan MC, Owen MJ. 2005. No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry 5:23.
13. Pin JP, Duvoisin R. 1995. The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 34:1-26.
14. Tochigi M, Suga M, Ohashi J, Otowa T, Yamasue H, Kasai K, Kato T, Okazaki Y, Kato N, Sasaki T. 2006. No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr Res 88:260-264.